8-K
Current Report
Protalix BioTherapeutics, Inc. Filed Acc 0000950123-08-007904
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading y63128e8vk.htm…